Cell Research | Huaqiang Xu collaborated with Wei Fu to reveal the Molecular basis of ligand recognition and activation of the human succinate receptor
It is found that succinic acid, once considered merely a tricarboxylic acid cycle intermediate, has been recognized for its significant role in influencing mitochondrial reactive oxygen species homeostasis. This is largely mediated through the G protein-coupled succinate receptor (SUCR1, also known as GPR91). A 2004 paper published in Nature identified succinate as the endogenous ligand of SUCR1.
More than a decade of research found that activation of SUCR1 had been implicated in the pathogenesis of liver fibrosis, hypertension, and rheumatic arthritis. Therefore, it is important to study the molecular mechanisms underlying SUCR1’s recognition and activation by ligands for understanding its physiological significance and therapeutic potentials as a target. In June 2024, Huaqiang Xu from Shanghai Institute of Materia Medica Chinese Academy of Sciences and Wei Fu from Fudan University published a paper on Cell Research, titled Molecular basis of ligand recognition and activation of the human succinate receptor SUCR1, reporting the unique ligand binding features and activation mechanism of human SUCR1.
Sungen Biomedical was founded in 2019 which is an innovative antibody drug research and development biology enterprise incubated by Hotgen Biotech (SH688068), a listed company on the Shanghai Stock Exchange. The co-founder of Sungen Biomedical is Professor Zhiwei Sun, Vice Chairman of China Monoclonal Antibody Industry Committee.
You must be logged in to post a comment.